Shandong Pharmaceutical Glass Co Ltd (600529) — Capital Reinvestment Ratio
Shandong Pharmaceutical Glass Co Ltd (600529) has a Capital Reinvestment Ratio of 3.69x as of December 2025, meaning it reinvests 4% of its operating cash flow (CN¥41.46 Million) in capital expenditures (CN¥153.18 Million). Check 600529 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Pharmaceutical Glass Co Ltd Capital Reinvestment Ratio (2001–2025)
This chart tracks Shandong Pharmaceutical Glass Co Ltd's Capital Reinvestment Ratio across 24 annual periods. For the full cash flow conversion analysis, see how efficiently does Shandong Pharmaceutical Glass Co Ltd generate cash.
Annual Capital Reinvestment Ratio for Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Pharmaceutical Glass Co Ltd from 2001 to 2025. See 600529 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.40x | CN¥576.92 Million | CN¥231.86 Million | ▼ -27.7% |
| 2024 | 0.56x | CN¥1.17 Billion | CN¥647.79 Million | ▼ -13.2% |
| 2023 | 0.64x | CN¥1.05 Billion | CN¥671.53 Million | ▼ -77.2% |
| 2022 | 2.82x | CN¥252.44 Million | CN¥710.71 Million | ▲ +161.1% |
| 2021 | 1.08x | CN¥750.44 Million | CN¥809.26 Million | ▲ +14.0% |
| 2020 | 0.95x | CN¥566.01 Million | CN¥535.20 Million | ▼ -4.3% |
| 2019 | 0.99x | CN¥599.05 Million | CN¥591.69 Million | ▲ +32.4% |
| 2018 | 0.75x | CN¥465.77 Million | CN¥347.38 Million | ▲ +83.9% |
| 2017 | 0.41x | CN¥411.96 Million | CN¥167.06 Million | ▲ +4.5% |
| 2016 | 0.39x | CN¥506.53 Million | CN¥196.58 Million | ▼ -2.5% |
| 2015 | 0.40x | CN¥389.63 Million | CN¥155.12 Million | ▼ -20.5% |
| 2014 | 0.50x | CN¥266.63 Million | CN¥133.53 Million | ▼ -10.6% |
| 2013 | 0.56x | CN¥268.60 Million | CN¥150.49 Million | ▼ -86.9% |
| 2012 | 4.28x | CN¥28.52 Million | CN¥122.10 Million | ▲ +440.5% |
| 2011 | 0.79x | CN¥274.63 Million | CN¥217.53 Million | ▼ -14.2% |
| 2010 | 0.92x | CN¥217.01 Million | CN¥200.37 Million | ▲ +94.3% |
| 2009 | 0.48x | CN¥249.27 Million | CN¥118.44 Million | ▼ -72.5% |
| 2008 | 1.73x | CN¥91.76 Million | CN¥158.40 Million | ▲ +31.6% |
| 2007 | 1.31x | CN¥122.63 Million | CN¥160.82 Million | ▲ +45.8% |
| 2006 | 0.90x | CN¥78.47 Million | CN¥70.59 Million | ▼ -53.4% |
| 2005 | 1.93x | CN¥44.09 Million | CN¥85.09 Million | ▼ -57.8% |
| 2003 | 4.58x | CN¥59.35 Million | CN¥271.74 Million | ▲ +344.7% |
| 2002 | 1.03x | CN¥109.26 Million | CN¥112.49 Million | ▲ +16.3% |
| 2001 | 0.89x | CN¥28.60 Million | CN¥25.32 Million | — |